JP2002501377A5 - - Google Patents

Download PDF

Info

Publication number
JP2002501377A5
JP2002501377A5 JP1998544147A JP54414798A JP2002501377A5 JP 2002501377 A5 JP2002501377 A5 JP 2002501377A5 JP 1998544147 A JP1998544147 A JP 1998544147A JP 54414798 A JP54414798 A JP 54414798A JP 2002501377 A5 JP2002501377 A5 JP 2002501377A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998544147A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002501377A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/007353 external-priority patent/WO1998046785A1/en
Publication of JP2002501377A publication Critical patent/JP2002501377A/ja
Publication of JP2002501377A5 publication Critical patent/JP2002501377A5/ja
Withdrawn legal-status Critical Current

Links

JP54414798A 1997-04-15 1998-04-15 樹状細胞ハイブリッド Withdrawn JP2002501377A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4360997P 1997-04-15 1997-04-15
US60/043,609 1997-04-15
PCT/US1998/007353 WO1998046785A1 (en) 1997-04-15 1998-04-15 Dendritic cell hybrids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008147567A Division JP2008263997A (ja) 1997-04-15 2008-06-05 樹状細胞ハイブリッド

Publications (2)

Publication Number Publication Date
JP2002501377A JP2002501377A (ja) 2002-01-15
JP2002501377A5 true JP2002501377A5 (cg-RX-API-DMAC7.html) 2005-12-02

Family

ID=21928022

Family Applications (2)

Application Number Title Priority Date Filing Date
JP54414798A Withdrawn JP2002501377A (ja) 1997-04-15 1998-04-15 樹状細胞ハイブリッド
JP2008147567A Pending JP2008263997A (ja) 1997-04-15 2008-06-05 樹状細胞ハイブリッド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008147567A Pending JP2008263997A (ja) 1997-04-15 2008-06-05 樹状細胞ハイブリッド

Country Status (8)

Country Link
US (1) US6652848B1 (cg-RX-API-DMAC7.html)
EP (1) EP1007720B1 (cg-RX-API-DMAC7.html)
JP (2) JP2002501377A (cg-RX-API-DMAC7.html)
AT (1) ATE388237T1 (cg-RX-API-DMAC7.html)
AU (1) AU744042B2 (cg-RX-API-DMAC7.html)
CA (1) CA2286873C (cg-RX-API-DMAC7.html)
DE (1) DE69839215T2 (cg-RX-API-DMAC7.html)
WO (1) WO1998046785A1 (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273753B2 (en) * 1996-08-02 2007-09-25 Center Of Blood Research Purification and uses of dendritic cells and monocytes
US20050169898A1 (en) 1997-04-15 2005-08-04 Jianlin Gong Cell fusions and methods of making and using the same
AU2001238236B2 (en) * 1997-04-15 2007-02-15 Dana-Farber Cancer Institute, Inc. Cytotoxic t lymphocytes activated by dendritic cell hybrids
JP2002500872A (ja) * 1998-01-26 2002-01-15 ジェンザイム・コーポレーション 免疫エフェクター細胞ハイブリッド
US6389455B1 (en) * 1998-09-22 2002-05-14 Richard C. Fuisz Method and apparatus for bouncing electronic messages
CN1353575A (zh) * 1999-03-31 2002-06-12 匹兹堡大学联邦制高等教育 用树状细胞一肿瘤细胞或树状细胞一病毒细胞衍生的免疫原在体外诱导抗原特异性t-销细胞
WO2001029193A2 (de) * 1999-10-22 2001-04-26 Peter Leskovar Zellkonstrukte, die für die immuntherapie geeignet sind, deren herstellung und verwendung
KR100363587B1 (ko) * 1999-11-12 2002-12-06 이시우 대식세포와 종양세포의 융합에 의한 항종양 세포성 치료제
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
US20070212338A1 (en) * 2000-01-11 2007-09-13 Greenville Hospital System Hybrid cells
US20090087450A1 (en) * 2000-01-11 2009-04-02 Greenville Hospital System Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
EP1541675A3 (en) * 2000-01-11 2007-08-08 Greenville Hospital System Hybrid cells obtainable from antigen presenting cells
ATE297981T1 (de) * 2000-01-11 2005-07-15 Greenville Hospital System Herstellung von vakzinen unter der verwendung von hybrid-zellen
EP1263928B1 (en) * 2000-02-11 2007-09-26 Dana-Farber Cancer Institute, Inc. Identification of antigenic peptides by cytotoxic t lymphocytes activated by dendritic cell hybrids
JP2003524020A (ja) * 2000-02-27 2003-08-12 エーバーハルト−カルルス−ウニヴェルズィテート テュービンゲン ウニヴェルズィテートクリーニクム ハイブリッド細胞ワクチン
DE10009030A1 (de) * 2000-02-27 2001-09-20 Univ Eberhard Karls Impfstoff
DE10024384A1 (de) * 2000-05-17 2001-11-29 Mack Gerd R Herstellung von dendritischen Zellen aus Rückenmarkstammzellen
JP2004511503A (ja) * 2000-10-20 2004-04-15 大野 典也 疾患を治療するための融合細胞およびサイトカイン組成物
DE10139428A1 (de) * 2001-08-17 2003-03-27 Nemod Immuntherapie Ag Herstellung und Verwendung von humanen CD124 und CD116 positiven Tumorzelllinien zur Herstellung von allogenen oder semi-allogenen Immuntherapeutika
US20040115224A1 (en) * 2002-12-16 2004-06-17 Tsuneya Ohno Preparation and administration of hybrid cell vaccines for the prevention of cancer
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050180951A1 (en) * 2004-02-12 2005-08-18 Tsuneya Ohno Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
WO2005083062A1 (ja) * 2004-02-26 2005-09-09 Genomidea Inc. 細胞ワクチン
CA2558382A1 (en) * 2004-03-02 2005-09-15 Tsuneya Ohno Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
WO2006095330A2 (en) * 2005-03-10 2006-09-14 Yeda Research And Development Co. Ltd. Methods and immunogenic cell preparations for treating antigen-associated diseases
CN101511384A (zh) * 2006-06-30 2009-08-19 贝勒研究院 采用GM-CSF和α干扰素制成的并装载热处理的且杀死的癌细胞的树突状细胞
CN109385400A (zh) * 2017-08-09 2019-02-26 科济生物医药(上海)有限公司 共表达pd-l1阻断剂的嵌合抗原受体修饰的免疫效应细胞
US20250319183A1 (en) 2021-04-07 2025-10-16 David Avigan Compositions and methods for the treatment of cancer
CA3228747A1 (en) * 2021-08-19 2023-02-23 Young Jik Kwon Antigen presenting cell/target cell hybridoma-derived vaccines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348878A (en) 1990-05-10 1994-09-20 Dana-Farber Cancer Institute Class I MHC-restricted T-T hybridomas, and a CD8-transfected BW5147, fusion partner therefor
AU687733B2 (en) 1992-04-01 1998-03-05 Rockefeller University, The Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
PT633929E (pt) 1992-04-01 2004-07-30 Merix Bioscience Inc Metodo para proliferacao (in vitro) de precursores de celulas dentifricas e sua utilizacao para produzir imunogenios
IT1264516B1 (it) 1993-05-31 1996-09-24 Biotop Sas Di Rita Cassarin Cellule dendritiche immortalizzate
DE69424299T2 (de) * 1993-10-01 2000-08-31 Minnesota Mining And Mfg. Co., St. Paul Sprachübertragungsadapter für eine atmungsmaske
WO1995016775A1 (en) 1993-12-14 1995-06-22 Yajun Guo Tumor cell fusions and methods for use of such tumor cell fusions
CA2199377A1 (en) 1994-09-09 1996-03-14 Zymogenetics, Inc. Preparation of immortalized cells
EP0839044B1 (en) 1995-03-31 2005-05-18 Universite Libre De Bruxelles Dendritic-like cell/tumor cell hybrids for inducing an anti-tumor response
EP0964694A4 (en) * 1996-10-25 2000-09-13 Dana Farber Cancer Inst Inc MUCIN-MEDIATED IMMUNOMODULATION
CN1353575A (zh) 1999-03-31 2002-06-12 匹兹堡大学联邦制高等教育 用树状细胞一肿瘤细胞或树状细胞一病毒细胞衍生的免疫原在体外诱导抗原特异性t-销细胞

Similar Documents

Publication Publication Date Title
JP2000509635A5 (cg-RX-API-DMAC7.html)
JP2000510751A5 (cg-RX-API-DMAC7.html)
JP2000507042A5 (cg-RX-API-DMAC7.html)
JP2001513776A5 (cg-RX-API-DMAC7.html)
JP2000509637A5 (cg-RX-API-DMAC7.html)
JP2002512615A5 (cg-RX-API-DMAC7.html)
JP2000515412A5 (cg-RX-API-DMAC7.html)
JP2000509587A5 (cg-RX-API-DMAC7.html)
JP2000507433A5 (cg-RX-API-DMAC7.html)
JP2002508747A5 (cg-RX-API-DMAC7.html)
JP2000508866A5 (cg-RX-API-DMAC7.html)
JP2000510793A5 (cg-RX-API-DMAC7.html)
JP2000508841A5 (cg-RX-API-DMAC7.html)
JP2000517086A5 (cg-RX-API-DMAC7.html)
JP2000508680A5 (cg-RX-API-DMAC7.html)
JP2002509600A5 (cg-RX-API-DMAC7.html)
JP2000509853A5 (cg-RX-API-DMAC7.html)
JP2000510247A5 (cg-RX-API-DMAC7.html)
JP2000510969A5 (cg-RX-API-DMAC7.html)
JP2001522458A5 (cg-RX-API-DMAC7.html)
JP2000508836A5 (cg-RX-API-DMAC7.html)
JP2000508102A5 (cg-RX-API-DMAC7.html)
JP2000509520A5 (cg-RX-API-DMAC7.html)
JP2000507434A5 (cg-RX-API-DMAC7.html)
JP2002515092A5 (cg-RX-API-DMAC7.html)